| 0 |
ADMINISTRATION SITE ECZEMA |
1 |
0.2500 |
| 1 |
APPLICATION SITE ODOUR |
2 |
0.0138 |
| 2 |
APPLICATION SITE ECZEMA |
1 |
0.0115 |
| 3 |
PARANASAL SINUS HYPOSECRETION |
1 |
0.0040 |
| 4 |
EPILEPTIC AURA |
1 |
0.0039 |
| 5 |
ANISOCORIA |
1 |
0.0026 |
| 6 |
MYDRIASIS |
31 |
0.0024 |
| 7 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 8 |
APPLICATION SITE INFLAMMATION |
3 |
0.0022 |
| 9 |
APPLICATION SITE IRRITATION |
26 |
0.0021 |
| 10 |
INTERTRIGO |
1 |
0.0018 |
| 11 |
APPLICATION SITE PAIN |
39 |
0.0018 |
| 12 |
APPLICATION SITE RASH |
23 |
0.0017 |
| 13 |
SYPHILIS |
1 |
0.0014 |
| 14 |
SKIN BACTERIAL INFECTION |
1 |
0.0012 |
| 15 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 16 |
APPLICATION SITE DISCOMFORT |
2 |
0.0011 |
| 17 |
HYPERMETROPIA |
1 |
0.0011 |
| 18 |
CHEMICAL BURN |
1 |
0.0009 |
| 19 |
CHRONIC SPONTANEOUS URTICARIA |
1 |
0.0009 |
| 20 |
DRY MOUTH |
63 |
0.0008 |
| 21 |
VISION BLURRED |
102 |
0.0007 |
| 22 |
URINARY RETENTION |
23 |
0.0007 |
| 23 |
ANTICHOLINERGIC SYNDROME |
1 |
0.0006 |
| 24 |
APPLICATION SITE BURN |
3 |
0.0006 |
| 25 |
APPLICATION SITE SWELLING |
3 |
0.0006 |
| 26 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 27 |
MUCOSAL DRYNESS |
1 |
0.0005 |
| 28 |
DRY THROAT |
5 |
0.0005 |
| 29 |
NIPPLE PAIN |
1 |
0.0005 |
| 30 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 31 |
APPLICATION SITE PRURITUS |
10 |
0.0004 |
| 32 |
URINE FLOW DECREASED |
1 |
0.0004 |
| 33 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 34 |
OSTEITIS |
1 |
0.0004 |
| 35 |
APPLICATION SITE ERYTHEMA |
10 |
0.0004 |
| 36 |
DYSURIA |
12 |
0.0003 |
| 37 |
SKIN EROSION |
1 |
0.0003 |
| 38 |
MICTURITION DISORDER |
1 |
0.0003 |
| 39 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 40 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 41 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 42 |
DRY EYE |
10 |
0.0002 |
| 43 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 44 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 45 |
SKIN WARM |
1 |
0.0002 |
| 46 |
NASAL DRYNESS |
1 |
0.0002 |
| 47 |
SENSITIVE SKIN |
1 |
0.0001 |
| 48 |
RHINITIS |
1 |
0.0001 |
| 49 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 50 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 51 |
SKIN LACERATION |
1 |
0.0001 |
| 52 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 53 |
MICTURITION URGENCY |
1 |
0.0001 |
| 54 |
SKIN IRRITATION |
4 |
0.0001 |
| 55 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 56 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 57 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 58 |
RASH PRURITIC |
4 |
0.0001 |
| 59 |
VISUAL IMPAIRMENT |
9 |
0.0001 |
| 60 |
APHONIA |
1 |
0.0001 |
| 61 |
SKIN REACTION |
1 |
0.0001 |
| 62 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 63 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 64 |
RASH |
24 |
0.0001 |
| 65 |
SINUS DISORDER |
1 |
0.0001 |
| 66 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 67 |
DERMATITIS |
1 |
0.0000 |
| 68 |
THROAT IRRITATION |
2 |
0.0000 |
| 69 |
HYPERSENSITIVITY |
8 |
0.0000 |
| 70 |
PRESYNCOPE |
1 |
0.0000 |
| 71 |
DIPLOPIA |
1 |
0.0000 |
| 72 |
JAUNDICE |
1 |
0.0000 |
| 73 |
URTICARIA |
6 |
0.0000 |
| 74 |
PAIN IN JAW |
1 |
0.0000 |
| 75 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 76 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 77 |
ERYTHEMA |
6 |
0.0000 |
| 78 |
BURNING SENSATION |
2 |
0.0000 |
| 79 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 80 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 81 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 82 |
EYE SWELLING |
1 |
0.0000 |
| 83 |
HOT FLUSH |
2 |
0.0000 |
| 84 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 85 |
BLINDNESS |
1 |
0.0000 |
| 86 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 87 |
ANGIOEDEMA |
1 |
0.0000 |
| 88 |
DYSPHAGIA |
2 |
0.0000 |
| 89 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 90 |
ECZEMA |
1 |
0.0000 |
| 91 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 92 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 93 |
DRUG INEFFECTIVE |
24 |
0.0000 |
| 94 |
BLISTER |
1 |
0.0000 |
| 95 |
EYE IRRITATION |
1 |
0.0000 |
| 96 |
CATARACT |
1 |
0.0000 |
| 97 |
OFF LABEL USE |
14 |
0.0000 |
| 98 |
DEHYDRATION |
2 |
0.0000 |
| 99 |
SLEEP DISORDER |
1 |
0.0000 |
| 100 |
PRURITUS |
5 |
0.0000 |
| 101 |
DRUG INTERACTION |
2 |
0.0000 |
| 102 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 103 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 104 |
CONTUSION |
1 |
0.0000 |
| 105 |
HEART RATE INCREASED |
1 |
0.0000 |
| 106 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 107 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 108 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 109 |
HEADACHE |
6 |
0.0000 |
| 110 |
DRY SKIN |
1 |
0.0000 |
| 111 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 112 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 113 |
HOSPITALISATION |
1 |
0.0000 |
| 114 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 115 |
PARAESTHESIA |
1 |
0.0000 |
| 116 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 117 |
MYALGIA |
1 |
0.0000 |
| 118 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 119 |
CHEST PAIN |
1 |
0.0000 |
| 120 |
CONSTIPATION |
1 |
0.0000 |
| 121 |
FEELING ABNORMAL |
1 |
0.0000 |
| 122 |
DIZZINESS |
2 |
0.0000 |
| 123 |
NAUSEA |
3 |
0.0000 |
| 124 |
INSOMNIA |
1 |
0.0000 |
| 125 |
COUGH |
1 |
0.0000 |
| 126 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 127 |
PYREXIA |
1 |
0.0000 |
| 128 |
MALAISE |
1 |
0.0000 |
| 129 |
DIARRHOEA |
1 |
0.0000 |
| 130 |
FATIGUE |
1 |
0.0000 |